Clinical

Dataset Information

0

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer


ABSTRACT: This is a phase II, open-label, non-randomized study in subjects with histologically confirmed diagnosis of left-sided RAS WT advanced adenocarcinoma of the colon or rectum who have not received prior systemic therapy for metastatic disease.

DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2322407 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-11-15 | GSE188711 | GEO
2024-06-10 | GSE176499 | GEO
2014-12-31 | GSE47908 | GEO
| PRJNA779978 | ENA
| PRJNA736439 | ENA
2019-11-25 | PXD012304 | Pride
| 2281790 | ecrin-mdr-crc
| PRJNA416367 | ENA
2022-02-17 | PXD027323 | Pride
| PRJNA257019 | ENA